Podcasts about pfizer biontech's covid

In a rare bipartisan move on Capitol Hill, Democrat Mike Levin and Republican Darrell Issa have re-introduced legislation on removing spent nuclear waste from San Onofre. Next, families with children under 5 will have to wait a while longer for Pfizer-BioNTech's COVID-19 vaccine to be available for small children. An explanation of the decision. Then, what should California do with its estimated $20 Billion budget surplus? Last year some of that surplus was returned in the form of stimulus checks for some Californians. And, a fourth grade High Tech elementary teacher was placed on administrative leave last week after reading a piece from a Harlem Renaissance poet that included an offensive word as part of a lesson. Later, California's mask mandates will be lifted again this week in many places, but they'll remain in congregate settings like immigrant detention centers where COVID-19 is still spreading. Finally, Black Comix Day returns this weekend at the WorldBeat Cultural Center in Balboa Park after a pandemic hiatus.

Included in this episode: 1. Should You Wear a Mask? What to Do as Mandates Roll Back 2. FDA Committee Delays Review of Pfizer-BioNTech's COVID-19 Vaccine for Young Kids 3. The History of Speed Skaters Brittany Bowe's and Erin Jackson's Friendship On And Off the Ice 4. Eric Adams Wants ‘Dangerousness' Factored into New York's Bail Laws. Advocates Say It Will Only Bring More Bias 5. What the Resignation of London's Top Police Chief Means for Boris Johnson .

Two doses of Pfizer-BioNTech's Covid-19 vaccine appear to provide 70 percent protection against hospitalisation from the Omicron coronavirus variant , according to an extensive real-world study in South Africa. The analysis released on Tuesday by South Africa's largest private health insurance administrator, Discovery Health, was based on more than 211,000 positive Covid-19 test results of adults from November 15 to December 7, about 78,000 of which were attributed to Omicron. The 78,000 results are not confirmed Omicron cases, meaning the study is not able to draw conclusive findings about the new strain, which the World Health Organization (WHO) has labelled a “variant of concern”. The discovery of Omicron was first announced in November by scientists in South Africa, and the country is the first to experience a surge in Covid-19 driven by the Omicron variant. BREAKING [Thread]: 1. SA's first real-world data on #Pfizer 's #Covid19 jab's protection @ #Omicron infection + hospitalisation via @Discovery_SA + @MRCza Note: This is data from the 1st 3 weeks of the outbreak, so it might change – regard it as preliminary real-world data Mia Malan (@miamalan) December 14, 2021 South African scientists have so far confirmed about 550 Omicron sequences, with the variant accounting for 78 percent of sequences from November, a higher share than the previously dominant Delta variant. The discovery of a new strain of the coronavirus last month triggered alarm that it could cause another surge in global infections, and led many countries to impose travel restrictions on the southern Africa region. South Africa's daily infections have since risen to almost 20,000 in recent days. Based on analysis by Discovery's clinical research and actuarial teams, and in collaboration with South Africa's Medical Research Council (SAMRC), the real-world study calculated that two doses of Pfizer-BioNTech offered 70 percent protection against hospitalisation during the recent surge in cases and 33 percent protection against infection. The level of protection is high considering that the WHO renders a Covid vaccine effective if it provides 50 percent protection . The study cites data gathered from the first three weeks of South Africa's Omicron-driven wave and may change as time passes. The researchers emphasised that its findings are preliminary and not peer-reviewed. South Africa is using the Pfizer-BioNTech and Johnson & Johnson vaccines in its Covid-19 immunisation campaign, with more than 20 million Pfizer doses administered so far. It concluded that there was a higher risk of reinfection during the fourth wave than during previous waves and that the risk of hospitalisation among adults diagnosed with Covid-19 was 29 percent lower than during the country's first wave early last year. Children appeared to have a 20 percent higher risk of hospital admission with complications during the fourth wave than during the first, despite a very low absolute incidence, it said. Discovery cautioned that the study's findings should be considered preliminary. Glenda Gray, SAMRC president, said it was important that the Pfizer-BioNTech vaccine appeared to be offering good protection against severe disease and hospitalisation.

When the FDA gave emergency-use authorization to Pfizer BioNTech's COVID-19 vaccine for children ages 5 to 11, many parents let out a collective sigh of relief. Parents also had questions on the safety of the vaccine for their children. Guest host Dr. Melissa Hogan, dean of the College of Science, Health and Pharmacy, speaks with Dr. Bedrija Nikocevic and Dr. Cathy DiVincenzo about the vaccine in young kids.Dr. Nikocevic is an assistant professor of clinical sciences in the Doctor of Pharmacy program. After working in community pharmacy for eight years, Dr. Nikocevic now cares for patients as a clinical pharmacist on Chicago's South Side.Dr. DiVincenzo is a pediatrician with a very successful private practice, Kids First Pediatric Partners. She also serves on Advocate Children's Hospital Physician Advisory Council and on the Advocate Lutheran General Physician Partners Board of Directors.This episode is part of our COVID-19 Vaccine Explained series. Since we recorded this podcast, the announcement of a new variant, Omicron, hit the news. While much is still unknown about the variant, vaccines still remain our most powerful tool against COVID-19. See acast.com/privacy for privacy and opt-out information.

The European Union's drug regulator approved the use of Pfizer-BioNTech's COVID-19 vaccine for children between the ages of five and 11 paving the way for them to be given the first shot as Europe struggles to contain a surge in infections. The European Medicines Agency recommended that Pfizer-BioNTech's vaccine, approved for EU use in teenagers between 12 and 17 years old be given as an injection in the upper arm in two 10 microgram doses, three weeks apart. The approval comes as Europe is again the epicentre of the pandemic, accounting for about half of cases and deaths.

The European Union's drug regulator approved the use of Pfizer-BioNTech's COVID-19 vaccine for children between the ages of five and 11 paving the way for them to be given the first shot as Europe struggles to contain a surge in infections. The European Medicines Agency recommended that Pfizer-BioNTech's vaccine, approved for EU use in teenagers between 12 and 17 years old be given as an injection in the upper arm in two 10 microgram doses, three weeks apart. The approval comes as Europe is again the epicentre of the pandemic, accounting for about half of cases and deaths.

The European Union's drug regulator approved the use of Pfizer-BioNTech's COVID-19 vaccine for children between the ages of five and 11 paving the way for them to be given the first shot as Europe struggles to contain a surge in infections. The European Medicines Agency recommended that Pfizer-BioNTech's vaccine, approved for EU use in teenagers between 12 and 17 years old be given as an injection in the upper arm in two 10 microgram doses, three weeks apart. The approval comes as Europe is again the epicentre of the pandemic, accounting for about half of cases and deaths.

Comprehensive coverage of the day's news with a focus on war and peace; social, environmental and economic justice. Voters put a Republican in Virginia's Governor seat, Democrat in New Jersey's Governor seat. Democrats put paid leave back into the Build Back Better Act, along with immigration reform. Supreme Court hears challenge to New York gun ban, appears poised to repeal it. Republican's block debate on voting rights bill for the 4th time. President Joe Biden says administration will launch COVID-19 vaccine program for children next week. U.S. health officials announce approval of Pfizer-BioNtech's COVID-19 vaccine for 5-11 year olds. The post Voters put a Republican in Virginia's Governor seat, Democrat in New Jersey's Governor seat; Supreme Court hears challenge to New York gun ban, appears poised to repeal it; U.S. health officials announce approval of Pfizer's COVID-19 vaccine for 5-11 year olds appeared first on KPFA.

In this episode, Ayesha discusses the FDA's authorization of Pfizer/BioNTech's COVID-19 vaccine for children between five and 11 years of age. The authorization was based on trial data that showed the vaccine was safe, well-tolerated and induced robust immune responses among children in this age group; side effects were generally mild to moderate. Amid concerns of the rare adverse event of myocarditis in children and adolescents following vaccination with mRNA vaccines, the FDA conducted its own benefit-risk analysis that showed the benefit of vaccination outweighs the risk of myocarditis. The editorial team discussed the positive trial data, the importance of vaccinating kids amid rising infections among younger children, as well as vaccine hesitancy among parents.The team also learned about the FDA approval of Genentech's new ocular implant drug delivery system, called Susvimo, for the treatment of neovascular, or wet, age-related macular degeneration (nAMD). The implant is surgically placed in the eye and injected with Genentech's anti-VEGFA monoclonal antibody ranibizumab for continuous delivery. Compared with the current standard of care of near monthly intravitreal anti-VEGF injections, the ocular implant only has to be refilled every six months. The team discussed the convenience of the device, but also potential patient hesitancy over the surgery for its implantation.Read the full articles here: FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Kids 5 to 11 Genentech's New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game ChangerFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured 

A.M. Edition for Sept. 24. WSJ's Keith Zhai discusses whether the heavily indebted property developer will meet its payments and why Beijing may let it fail. U.S. Commerce Secretary Gina Raimondo says she will seek to improve American business ties with China. A CDC panel recommends a booster of Pfizer-BioNTech's Covid-19 vaccine for seniors, nursing-home residents and certain adults with underlying medical conditions. And, how to make networking a little less painful. Peter Granitz hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices

更多通勤學英語Podcast單元: 每日英語跟讀Podcast，就在http://www.15mins.today/daily-shadowing 精選詞彙 VOCAB Podcast，就在https://www.15mins.today/vocab 語音直播 15mins Live Podcast, 就在https://www.15mins.today/15mins-live-podcast 文法練習 In-TENSE Podcast，就在https://www.15mins.today/in-tense 歡迎到官網用email訂閱我們節目更新通知。   老師互動信箱: ask15mins@gmail.com 商業合作洽詢: 15minstoday@gmail.com   每日英語跟讀 Ep.K196: Disinformation for Hire, a Shadow Industry, Is Quietly Booming   In May, several French and German social media influencers received a strange proposal. 幾個法國和德國的社群網紅，5月時收到一份怪異的提案。 A London-based public relations agency wanted to pay them to promote messages on behalf of a client. A polished three-page document detailed what to say and on which platforms to say it. 一家位於倫敦的公關公司想付費給他們，為一名客戶推廣訊息。字句精練的三頁文件詳細交代要說什麼，以及在哪個平台上說。 But it asked the influencers to push not beauty products or vacation packages, as is typical, but falsehoods tarring Pfizer-BioNTech's COVID-19 vaccine. Stranger still, the agency, Fazze, claimed a London address where there is no evidence any such company exists. 但是它要求網紅推銷的不是典型的美容產品或套裝旅遊，而是抹黑輝瑞BNT新冠疫苗的不實訊息。更怪的是，這家名叫Fazze的公司雖宣稱有倫敦地址，當地卻沒這家公司存在的證據。 The scheme appears to be part of a secretive industry that security analysts and U.S. officials say is exploding in scale: disinformation for hire. 這個計畫看起來像是安全專家和美國官員所說，正在大規模擴張的祕密產業一部分：雇傭傳播假訊息。 Private firms, straddling traditional marketing and the shadow world of geopolitical influence operations, are selling services once conducted principally by intelligence agencies. 私人公司跨越傳統行銷和地緣政治影響力行動的陰暗世界，正販售過去主要由情報機構執行的服務。 “Disinfo-for-hire actors being employed by government or government-adjacent actors is growing and serious,” said Graham Brookie, director of the Atlantic Council's Digital Forensic Research Lab, calling it “a boom industry.” 大西洋理事會「數位鑑識研究實驗室」主任葛拉罕．布魯奇說，「受政府或政府相關單位雇用傳播假訊息的人，正不斷增加且日趨嚴重」，這是個「繁榮產業」。 For-hire disinformation, though only sometimes effective, is growing more sophisticated as practitioners iterate and learn. Experts say it is becoming more common in every part of the world, outpacing operations conducted directly by governments. 受雇傳播假訊息固然僅偶爾有效，但在執行者反覆學習之下變得更精妙。專家說，這項產業變得在世界每個角落更普遍，勝過政府直接進行的任務。 The trend emerged after the Cambridge Analytica scandal in 2018, experts say. Cambridge, a political consulting firm linked to members of Donald Trump's 2016 presidential campaign, was found to have harvested data on millions of Facebook users. 專家說，這個趨勢在2018年的劍橋分析醜聞後興起。這家政治顧問公司和川普2016年總統大選競選活動的成員有關聯，被發現收集數百萬名臉書用戶數據。 Cambridge used its data to target hyperspecific audiences with tailored messages. It tested what resonated by tracking likes and shares. 劍橋分析利用數據，以量身訂做的訊息來針對極端特定受眾，它利用追蹤「讚」和「分享」測試哪些訊息獲得反應。 The episode taught a generation of consultants and opportunists that there was big money in social media marketing for political causes, all disguised as organic activity. 這起事件讓同一世代的顧問和機會主義者學到，出於政治因素、偽裝成自然活動的社群媒體行銷大有錢景。 Some newcomers eventually reached the same conclusion as Russian operatives had in 2016: Disinformation performs especially well on social platforms. 一些新進者最終也獲得和俄羅斯人員在2016年得到的相同結論：假訊息在社群平台上表現得特別好。 At the same time, backlash to Russia's influence-peddling appeared to have left governments wary of being caught — while also demonstrating the power of such operations. 同時，對俄國操弄影響力的反彈，顯然讓政府在展示這類行動的力量時，也擔憂會被抓個正著。 “There is, unfortunately, a huge market demand for disinformation,” Brookie said, “and a lot of places across the ecosystem that are more than willing to fill that demand.” 「不幸的是，對於假訊息有巨大的市場需求。」布魯奇說，「而這個生態系的許多地方非常樂於滿足這項需求。」Source article: https://udn.com/news/story/6904/5656426  

How Full FDA Approval of Pfizer Vaccine Could Impact the Fight Against COVID-19 On Monday, the FDA fully approved Pfizer-BioNTech's Covid-19 vaccine for people ages 16 and older. A poll released by the Kaiser Family Foundation at the end of June found that three out of ten unvaccinated adults said they would be more likely to get vaccinated if the FDA granted its full approval to one of the vaccines.  COVID Cases Surge in Alabama As ICU's Run Out of Beds  The delta variant of COVID-19 is hitting hard in the Southern United States. Alabama has seen a 59% increase in hospitalizations over the past two weeks, with ICU's at 100 percent capacity. The Takeaway spoke with Sarah Nafziger, vice president of clinical support services at University of Alabama Hospital. Julius Jones Fights for Commutation  On September 13, 2021, the Oklahoma Pardon and Parole Board will decide whether to commute the sentence of Julius Jones who has been in prison for 20 years. Jones maintains his innocence saying, “I have spent the past twenty years on death row for a crime I did not commit, did not witness, and was not at.” At issue in Jones' case are a potential racist juror, ineffective counsel, and the fact that no witnesses were allowed to testify for Jones to present his alibi.    A Host of Problems for Jeopardy!  Mike Richards, who is the executive producer of Jeopardy!, was recently named host of the beloved quiz show. But after an article from the Ringer revealed offensive and misogynistic comments made by Richards as the host of a podcast called The Randumb Show, he announced that he would be stepping aside from the hosting role of Jeopardy!. For transcripts, see individual segment pages.  

How Full FDA Approval of Pfizer Vaccine Could Impact the Fight Against COVID-19 On Monday, the FDA fully approved Pfizer-BioNTech's Covid-19 vaccine for people ages 16 and older. A poll released by the Kaiser Family Foundation at the end of June found that three out of ten unvaccinated adults said they would be more likely to get vaccinated if the FDA granted its full approval to one of the vaccines.  COVID Cases Surge in Alabama As ICU's Run Out of Beds  The delta variant of COVID-19 is hitting hard in the Southern United States. Alabama has seen a 59% increase in hospitalizations over the past two weeks, with ICU's at 100 percent capacity. The Takeaway spoke with Sarah Nafziger, vice president of clinical support services at University of Alabama Hospital. Julius Jones Fights for Commutation  On September 13, 2021, the Oklahoma Pardon and Parole Board will decide whether to commute the sentence of Julius Jones who has been in prison for 20 years. Jones maintains his innocence saying, “I have spent the past twenty years on death row for a crime I did not commit, did not witness, and was not at.” At issue in Jones' case are a potential racist juror, ineffective counsel, and the fact that no witnesses were allowed to testify for Jones to present his alibi.    A Host of Problems for Jeopardy!  Mike Richards, who is the executive producer of Jeopardy!, was recently named host of the beloved quiz show. But after an article from the Ringer revealed offensive and misogynistic comments made by Richards as the host of a podcast called The Randumb Show, he announced that he would be stepping aside from the hosting role of Jeopardy!. For transcripts, see individual segment pages.  

Stocks Rally Monday, FDA Grants Full Approval to Pfizer-BioNTech's Covid Shot, Proposition 22 in California Ruled Unconstitutional, Dividend Payout Reaches $1.4 Trillion in 2021, and PayPal Launches a Cryptocurrency Service in the U.K.

Town Square with Ernie Manouse airs at 3 p.m. CT. Tune in on 88.7FM, listen online or subscribe to the podcast. Join the discussion at 888-486-9677, questions@townsquaretalk.org or @townsquaretalk. News broke this morning that a lot of people have been waiting for. The Food and Drug Administration has formally approved Pfizer-BioNTech's COVID-19 vaccine. Today's FDA approval replaces the emergency use authorization given last December. What does FDA approval actually mean, and what do we need to understand about the process that got us here? What are the consequences of FDA approval?  Will it make the vaccine easier to mandate or distribute, and could it increase vaccination rates? Today, medical experts are here to explain, and we'll also cover back-to-school and COVID. Guests: Dr. Michael Chang Pediatric infectious diseases specialist at UTHealth and Children's Memorial Hermann Hospital Dr. James McDeavitt Executive Vice President and Dean of Clinical Affairs at Baylor College of Medicine He writes the blog "COVID-19 Updates from Dr. James Deavitt" for Baylor College of Medicine During the show, Dr. Chang referred to these websites in response to a listener question. Both are programs run by the Department of Health and Human Services and have publicly available data: National Vaccine Injury Compensation Program: https://www.hrsa.gov/vaccine-compensation/index.html Countermeasures Injury Compensation Program https://www.hrsa.gov/cicp Comparison between the two programs https://www.hrsa.gov/cicp/cicp-vicp Town Square with Ernie Manouse is a gathering space for the community to come together and discuss the day's most important and pressing issues. Audio from today's show will be available after 5 p.m. CT. We also offer a free podcast here, on iTunes, and other apps.

Monday, August 23, 2021 Subscribe: Get the Daily Update in your inbox for free 1/ The FDA granted full approval to the Pfizer-BioNTech's COVID-19 vaccine, clearing the path to more vaccine mandates at hospitals, colleges, corporations and other organizations across the country. The vaccine is now officially approved for all ... Visit WTF Just Happened Today? for more news and headlines, brought to you by Matt Kiser. The WTFJHT Podcast is narrated and produced by Joe Amditis.

United Torah Judaism party chief MK Moshe Gafni blasted Prime Minister Naftali Bennett and his government Sunday, during a visit to a Bnei Brak clinic to receive a COVID vaccination. Gafni, who visited a Clalit clinic Sunday morning to receive a third dose of the Pfizer-BioNTech's COVID vaccine, lashed out against Bennett immediately after he got the jab, while expressing his support for former Prime Minister and Opposition Leader Benjamin Netanyahu. “I thank Benjamin Netanyahu for bringing us the vaccines,” Gafni said, before blasting Bennett, accusing him of “not doing this immediately, and waiting a month until he decided” to move forward with the third dose of the COVID vaccine.” “Heaven is not helping this government,” Gafni added. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/yaar-ben-emmett/support

Dr. DJ Bandoy breaks down the results of the European Medicines Agency clinical trials of Pfizer-BioNTech's COVID vaccine on 12 to 15 year olds. For more questions about COVID-19, email us at askdocbandoy@gmail.com. See omnystudio.com/listener for privacy information.

Dr. DJ Bandoy breaks down the results of the European Medicines Agency clinical trials of Pfizer-BioNTech's COVID vaccine on 12 to 15 year olds. For more questions about COVID-19, email us at askdocbandoy@gmail.com. See omnystudio.com/listener for privacy information.

US Centers for Disease Control and Prevention advisers voted unanimously Wednesday to recommend giving Pfizer/BioNTech's Covid-19 vaccine to kids as young as 12. The CDC's Advisory Committee on Immunization Practices agreed the benefits of vaccinating children and teens outweigh any risks from the vaccine. The US Food and Drug Administration extended its emergency use authorization for the vaccine in 12-15-year-olds Monday. "This is one more step to gaining immunity and bringing the pandemic closer to an end," said Dr. José Romero, who chairs ACIP and who is also the Secretary of the Arkansas Department of Health.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

West Coast Cookbook & Speakeasy is Now Open! 8am-9am PT/ 11am-Noon ET for our especially special Daily Specials, Metro Shrimp & Grits Thursdays!Starting off in the Bistro Cafe, after twenty years, “it's time to turn the page” on Afghanistan.Then, on the rest of the menu, the Senate Homeland Security and Government Affairs Committee will consider Biden's three Postal Board of Governors nominees on 22 April; Federal Reserve Chair Jerome Powell defended the Fed's consideration of climate change risks to the economy; and, an epic drought has caused a water crisis among farmers, tribes and environmentalists on the Oregon-California border.After the break, we move to the Chef's Table where the Biden administration will announce sanctions in response to a massive Russian hacking campaign that breached vital federal agencies; and, in a stinging rebuke to pharma giant AstraZeneca, the EU threw its weight behind the Pfizer-BioNTech's COVID-19 vaccine.All that and more, on West Coast Cookbook & Speakeasy with Chef de Cuisine Justice Putnam.Bon Appétit!~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~“Everyone in this good city enjoys the full right to pursue his own inclinations in all reasonable and, unreasonable ways.” -- The Daily Picayune, New Orleans, March 5, 1851~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Show Notes & Links: https://www.dailykos.com/stories/2021/4/15/2026009/-West-Coast-Cookbook-amp-Speakeasy-Daily-Special-Metro-Shrimp-amp-Grits-Thursdays

Guest: Prof Mosa Moshabela | Acting Deputy Vice-Chancellor of Research and Innovation at University Of Kwa-Zulu Natal A study has found that the coronavirus variant discovered in SA can "break through" the Pfizer-BioNTech's Covid-19 vaccine. The Israeli study compared 400 people who tested positive for covid-19. Researchers have cautioned that the study was not intended to deduce overall vaccines effectiveness against any variant. Dr Mosa Moshabela, Acting Deputy Vice-Chancellor of Research and Innovation at the University of Kwa-Zulu Natal.   See omnystudio.com/listener for privacy information.

In this episode of the Xtalks Life Science Podcast, Ayesha discusses a report from the Center for Countering Digital Hate (CCDH) and Anti-Vax Watch that shows there are just 12 people behind 65 percent of all online anti-vaccine disinformation. While social media operators such as Facebook and Twitter had vowed to remove vaccine disinformation from their platforms, the disinformation dozen are still active and well on the sites. How can online misinformation be better combatted and are stricter actions on the part of social media networks needed? Ayesha also talks about the latest clinical trial results for Pfizer/BioNTech's COVID-19 vaccine. New data shows that the vaccine is safe and effective in children, performs extremely well against some of the new variants and vaccine-generated immune responses last for up to six months. While the new data is exciting and can help build greater confidence in the vaccine, can there be such a thing as too much information, and too fast, especially since data around the vaccines is evolving so quickly?Read the full articles here:Disinformation Dozen: The Anti-Vaxxers Behind Most Social Media MisinformationPfizer/BioNTech COVID-19 Vaccine Trial Results: Stellar, Long-Ranging Efficacies in Children and Against VariantsFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks, @XtalksMedDevice Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

Americans got some good news on Wednesday morning when the White House announced that it had secured another 100 million doses of the Pfizer-BioNTech's COVID-19 vaccine.Secretary of Health and Human Services Alex Azar released a statement afterward saying the U.S. will now have enough supply "to vaccinate every American who wants it by June 2021." Even with these announcements questions remain on how exactly everyone will get vaccinated. States are having varying levels of success with the vaccine rollout process. Dr. Jose Romero, Arkansas health secretary and chair of the Centers for Disease Control and Prevention immunization advisory committee, discusses the success Arkansas has had with vaccine distribution and the lessons learned in the process.In Seattle, NPR's Will Stone has been following vaccine distribution, including to health care workers who have been caring for COVID-19 patients for nearly a year. One of the questions that remains as more people get vaccinated is should volunteers who got a placebo during the vaccine trials now be offered the real thing? NPR's Ari Shapiro speaks with Dr. Steven Goodman of Stanford School of Medicine who is advising the Food and Drug Administration about this.In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.

The federal government has given the green light to the Pfizer-BioNTech's COVID-19 vaccine, a key step toward launching the largest inoculation campaign in Canada's history. Childhood Christmas gift memories… Gary Bettman: "If everything stays the way it is, we're probably going to have to have a Canadian division and realign in the U.S., and we're trying to focus on dealing with all of those challenges." An all-Canadian division would obviously include the Montreal Canadiens, Ottawa Senators, Toronto Maple Leafs, Calgary Flames, Edmonton Oilers, Vancouver Canucks and Winnipeg Jets. The 24 U.S.-based teams will likely be separated into three divisions, with eight teams in each. Will players have the right to opt out…will it be mandatory to get vaccines….

UK becomes first country to approve coronavirus vaccine : The United Kingdom has become the first country in the world to approve a Covid-19 vaccine for public use. On Wednesday, Pfizer and BioNTech said they'd been given permission for emergency use of their vaccine. It means the Pfizer-BioNTech vaccine is the world's first coronavirus shot backed by rigorous science. This marks a major step towards eventually ending the global coronavirus pandemic. British media have reported that hospitals in England have been told to get ready to start doing vaccinations for medical workers as early as next week --- Send in a voice message: https://anchor.fm/aziz-mustaphi/message